München: Die Entwicklung der Gentherapie macht Fortschritte mit gewebespezifischen AAV Plasmiden von Europas führendem Hersteller viraler Vektoren, SIRION Biotech in München
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.